13F Pro

SEC Form 4 reporting owner

Balcom Alexandra

Balcom Alexandra has filed 48 Form 4 transactions reported between December 8, 2025 and July 15, 2026, as Chief Financial Officer of Nuvalent, Inc. and Director of CRESCENT BIOPHARMA, INC..

Name as filed: Balcom Alexandra

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$8.8M
28 lines
Companies
2
with Form 4 filings
Latest transaction
Jul 15, 2026
transaction date

Roles and reported holdings

  • NUVLNuvalent, Inc.
    Dec 8, 2025 – Jul 15, 2026

    Chief Financial Officer

    Held directly85,533 sh as of Jul 1, 2026 · Form 4

    24 months: $8.8M sold

  • CBIOCRESCENT BIOPHARMA, INC.
    Jun 2, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 48 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 15, 2026NUVLChief Financial OfficerDisposition to issuerCode D · direct17,500—Form 4
Jul 15, 2026NUVLChief Financial OfficerDisposition to issuerCode D · direct37,500—Form 4
Jul 15, 2026NUVLChief Financial OfficerDisposition to issuerCode D · direct33,646—Form 4
Jul 15, 2026NUVLChief Financial OfficerDisposition to issuerCode D · direct84,200—Form 4
Jul 15, 2026NUVLChief Financial OfficerDisposition to issuerCode D · direct22,933—Form 4
Jul 15, 2026NUVLChief Financial OfficerDisposition to issuerCode D · direct8,016—Form 4
Jul 15, 2026NUVLChief Financial OfficerDisposition to issuerCode D · direct131,637—Form 4
Jul 15, 2026NUVLChief Financial OfficerGrant or awardCode A · direct14,350—Form 4
Jul 15, 2026NUVLChief Financial OfficerDisposition to issuerCode D · direct41,100—Form 4
Jul 15, 2026NUVLChief Financial OfficerTender in change of controlCode U · direct44,433$5.5M@ $124.00Form 4
Jul 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct11,430$1.4M@ $123.58Form 4
Jul 1, 2026NUVLChief Financial OfficerOption exerciseCode M · direct6,046$114K@ $18.93Form 4
Jul 1, 2026NUVLChief Financial OfficerOption exerciseCode M · direct5,384$37K@ $6.89Form 4
Jun 2, 2026CBIODirectorGrant or awardCode A · direct11,050—Form 4
Jun 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct200$21K@ $103.84Form 4
Jun 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct279$28K@ $101.79Form 4
Jun 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct2,588$260K@ $100.65Form 4
Jun 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct3,133$313K@ $99.86Form 4
Jun 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct1,200$118K@ $98.57Form 4
Jun 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct900$88K@ $97.68Form 4
Jun 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct2,170$208K@ $95.99Form 4
Jun 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct960$91K@ $94.87Form 4
Jun 1, 2026NUVLChief Financial OfficerOption exerciseCode M · direct11,430$79K@ $6.89Form 4
May 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct124$12K@ $99.97Form 4
May 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct7,434$738K@ $99.29Form 4
May 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct3,872$381K@ $98.42Form 4
May 1, 2026NUVLChief Financial OfficerOption exerciseCode M · direct4,271$29K@ $6.89Form 4
May 1, 2026NUVLChief Financial OfficerOption exerciseCode M · direct7,159$8K@ $1.08Form 4
Apr 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct2,469$262K@ $106.18Form 4
Apr 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct5,417$570K@ $105.30Form 4
Apr 1, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct3,544$370K@ $104.39Form 4
Apr 1, 2026NUVLChief Financial OfficerOption exerciseCode M · direct11,430$12K@ $1.08Form 4
Mar 25, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct13,700$1.4M@ $100.16Form 4
Mar 24, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct1,160$112K@ $96.50Form 4
Mar 24, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct7,671$735K@ $95.88Form 4
Mar 24, 2026NUVLChief Financial OfficerOpen-market saleCode S · direct2,599$247K@ $95.03Form 4
Mar 24, 2026NUVLChief Financial OfficerOption exerciseCode M · direct11,430$12K@ $1.08Form 4
Jan 7, 2026NUVLChief Financial OfficerGrant or awardCode A · direct17,500—Form 4
Jan 6, 2026NUVLChief Financial OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Turner Christopher Durant225$22K@ $98.40Form 4
Jan 6, 2026NUVLChief Financial OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Turner Christopher Durant1,635$159K@ $97.33Form 4
Jan 6, 2026NUVLChief Financial OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Turner Christopher Durant1,321$128K@ $96.75Form 4
Jan 5, 2026NUVLChief Financial OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Turner Christopher Durant317$31K@ $98.52Form 4
Jan 5, 2026NUVLChief Financial OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Turner Christopher Durant1,929$189K@ $97.96Form 4
Jan 5, 2026NUVLChief Financial OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Turner Christopher Durant1,119$108K@ $96.85Form 4
Jan 5, 2026NUVLChief Financial OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Turner Christopher Durant871$84K@ $96.06Form 4
Dec 22, 2025NUVLChief Financial OfficerOption exerciseCode M · direct34,500$37K@ $1.08Form 4
Dec 8, 2025NUVLChief Financial OfficerOpen-market saleCode S · direct100$11K@ $111.32Form 4
Dec 8, 2025NUVLChief Financial OfficerOpen-market saleCode S · direct6,984$770K@ $110.31Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.